News and Publications

ASTRO comments to the Centers for Medicare and Medicaid Services regarding their proposed radiation oncology alternative payment model

ARLINGTON, Va., September 16, 2019

In response to the Centers for Medicare and Medicaid Services' (CMS) request for comment on their proposed advanced alternative payment model (APM) for radiation oncology, the American Society for Radiation Oncology (ASTRO) submitted comments and issued the following statement today from Paul Harari, MD, FASTRO, Chair of the ASTRO Board of Directors:

“ASTRO appreciates CMS’ decision to move forward with an alternative payment model for radiation oncology and believes there are some positive elements in the proposed Radiation Oncology Model (RO Model). We are concerned, however, that the proposal by the Agency falls short of meeting three key goals established by ASTRO for the successful development of an alternative payment model. These goals are that the RO Model should:

  • Reward radiation oncologists for participation and performance in quality initiatives that improve the value of health care for patients;
  • Ensure fair, predictable payment for the radiation oncologist in both hospital and freestanding cancer clinics to protect cancer patients’ access to care in all settings; and
  • Incentivize the appropriate use of cancer treatments that result in the highest quality of care and best patient outcomes.

We recognize that CMS has sought to align some of the proposal with the Radiation Oncology Alternative Payment Model concept paper that ASTRO submitted in April 2017. Key elements from that paper are found in the proposed rule including the prospective payment; the episode trigger mechanism, timeline and clean period; establishment of distinct professional component and technical component payments; the inclusion of all modalities of treatment; and key quality measure elements. We thank the Agency for recognizing the effort that ASTRO has put into the development of an APM for radiation oncology.

However, an ASTRO analysis estimates that the RO Model would cut payments to required participants by approximately $320 million during the 5-year period—an excessive amount that would undermine this unique opportunity. For the model to be successful, ASTRO recommends specific, significant changes to the proposal that will incentivize the use of high-quality, efficient radiation therapy treatments that drive value-based reform while still providing savings for Medicare. A summary of the key issues and corresponding ASTRO recommendations follow:

Mandatory Participation. Requiring participation representing 40% of radiation oncology episodes goes too far for an untested model. ASTRO recommendation: CMS should launch the model as voluntary, then transition to mandatory on a limited basis, including opt-outs for low-volume practices and hardship exceptions.

National Case Rates. There are serious flaws in the calculation approach for the national case rates that would result in significant and unfair payment penalty for participants. We are concerned that the methodology fails to appropriately account for a range of complex clinical scenarios and average treatment costs for many clinics. ASTRO recommendation: CMS must include some physician fee schedule costs, properly attribute palliative care cases, and ensure adequate payments for patients receiving standard-of-care multi-modality treatments, such as combination therapy for gynecological cancer.

Discount Factor and Efficiency Adjustment. These proposed payment adjustments could result in significant cuts to all participants and unfairly disadvantage “efficient” practices. ASTRO recommendation: CMS should adjust the efficiency factor to avoid penalizing efficient practices and scale back the discount factors, which put at risk patient access by causing significant financial issues for such a capital expenditure intensive specialty.

APM Incentive Payment. CMS’ selective waiver of the 5% APM incentive payment on freestanding center technical payments undercuts the spirit and letter of MACRA’s intent of encouraging providers to assume risk and participate in APMs. ASTRO recommendation: CMS should remove this waiver.

Innovation. Innovation in radiation oncology has contributed greatly to increased cure rates and reduced side effects from treatment. Yet, the RO Model does not adequately account for the next generation of advances in the delivery of radiation oncology. Practices should be able to continue to invest in innovations that provide clinical benefit for patients. ASTRO recommendation: CMS should pay for new technology at fee-for-service rates and adopt a rate review mechanism for new service lines and upgrades.

Burden. The proposed RO Model would heap additional administrative tasks and costly requirements on already burdened radiation oncology practices that are required to participate in the model. ASTRO recommendation: CMS should delay many of these requirements and rely heavily on recommendations from the radiation oncology community to ensure that only information that is most meaningful and least burdensome is collected.

We believe the RO Model, with significant modifications, could represent a meaningful and viable first step toward enabling the field of radiation oncology to participate in the evolving world of health care payment reform as initiated by MACRA. We are committed to working with the Agency to modify the model in such a way that it meets the stated goals.”

A copy of ASTRO’s full response is available here.

ABOUT ASTRO
The American Society for Radiation Oncology (ASTRO) is the world’s largest radiation oncology society , with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. The Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the nonprofit foundation Radiation Oncology Institute. To learn more about ASTRO, visit our website, sign up to receive our news and follow us on our blog, Facebook, Twitter and LinkedIn.

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.